{"protocolSection": {"identificationModule": {"nctId": "NCT00990665", "orgStudyIdInfo": {"id": "60024498/E"}, "organization": {"fullName": "Abbott Medical Devices", "class": "INDUSTRY"}, "briefTitle": "Promote Q Cardiac Resynchronization Therapy Defibrillator (CRT-D) and Quartet Left Ventricular Heart Lead Study", "officialTitle": "Promote Q CRT-D and Quartet Left Ventricular Heart Lead Study", "acronym": "Promote Q"}, "statusModule": {"statusVerifiedDate": "2019-02", "overallStatus": "COMPLETED", "expandedAccessInfo": {"hasExpandedAccess": false}, "startDateStruct": {"date": "2009-09"}, "primaryCompletionDateStruct": {"date": "2010-09", "type": "ACTUAL"}, "completionDateStruct": {"date": "2012-07", "type": "ACTUAL"}, "studyFirstSubmitDate": "2009-10-06", "studyFirstSubmitQcDate": "2009-10-06", "studyFirstPostDateStruct": {"date": "2009-10-07", "type": "ESTIMATED"}, "resultsFirstSubmitDate": "2016-09-20", "resultsFirstSubmitQcDate": "2019-02-07", "resultsFirstPostDateStruct": {"date": "2019-02-27", "type": "ACTUAL"}, "lastUpdateSubmitDate": "2019-02-07", "lastUpdatePostDateStruct": {"date": "2019-02-27", "type": "ACTUAL"}}, "sponsorCollaboratorsModule": {"responsibleParty": {"type": "SPONSOR"}, "leadSponsor": {"name": "Abbott Medical Devices", "class": "INDUSTRY"}}, "oversightModule": {"oversightHasDmc": true}, "descriptionModule": {"briefSummary": "The objective of this study is to assess the safety and efficacy of the Quartet\u2122 lead and Promote Q\u00ae device system in a patient population indicated for cardiac resynchronization therapy."}, "conditionsModule": {"conditions": ["Heart Failure"], "keywords": ["CRT", "Heart Failure", "LV Leads"]}, "designModule": {"studyType": "INTERVENTIONAL", "phases": ["NA"], "designInfo": {"allocation": "NA", "interventionModel": "SINGLE_GROUP", "primaryPurpose": "TREATMENT", "maskingInfo": {"masking": "NONE"}}, "enrollmentInfo": {"count": 178, "type": "ACTUAL"}}, "armsInterventionsModule": {"armGroups": [{"label": "CRT-D and LV lead", "type": "EXPERIMENTAL", "interventionNames": ["Device: CRT-D and LV lead (Quartet\u2122 lead and Promote Q\u00ae device system)"]}], "interventions": [{"type": "DEVICE", "name": "CRT-D and LV lead (Quartet\u2122 lead and Promote Q\u00ae device system)", "description": "Promote Q CRT-D and Quartet LV lead", "armGroupLabels": ["CRT-D and LV lead"]}]}, "outcomesModule": {"primaryOutcomes": [{"measure": "Freedom From Left Ventricular Lead-Related Complications Through 3 Months", "description": "The primary safety endpoint for this study is freedom from left ventricular lead-related complications through 3 months.", "timeFrame": "3 months"}, {"measure": "Freedom From System-related Complications Through 3 Months", "description": "The co-primary safety endpoint for this study is freedom from system-related complications through 3 months.", "timeFrame": "3 Months"}, {"measure": "The Primary Effectiveness Endpoint for the Promote Q System Was the Responder Rate to Biventricular Pacing at 3 Months.", "description": "The primary effectiveness endpoint for the Promote Q system was the responder rate to biventricular pacing at 3 months. A responder per protocol was defined as a patient with an LV pacing threshold of \\<2.5 V at 0.5ms in the D1-M2 pacing configuration (Vector 1) AND at least one other non-standard programmable biventricular lead vector. Non-standard vectors included Vector 2 (D1-P4), Vector 4 (M2-P4), Vector 6 (M3-M2), Vector 7 (M3-P4), Vector 8 (M3-RV coil), Vector 9 (P4-M2) and Vector 10 (P4-RV coil).", "timeFrame": "3 Months"}]}, "eligibilityModule": {"eligibilityCriteria": "Inclusion Criteria:\n\n* Approved indication per ACC/AHA/HRS guidelines for implantation of a CRT-D system for treatment of heart failure or lifethreatening ventricular tachyarrhythmia(s)\n* Receiving a new implant or undergoing an upgrade from an existing ICD or pacemaker implant with no prior LV lead placement.\n* Ability to provide informed consent for study participation and is willing and able to comply with the prescribed follow-up tests and schedule of evaluations\n\nExclusion Criteria:\n\n* Have had a recent CVA or TIA within three months of enrollment\n* Have a contraindication for an emergency thoracotomy\n* Have a hypersensitivity to a single 1.0mg dose of dexamethasone sodium phosphate or short term contact with heparin\n* Have a classification of Status 1 for cardiac transplantation or consideration for transplantation over the next 3 months\n* Have undergone a cardiac transplantation within 40 days of enrollment\n* Have had a recent myocardial infarction, unstable angina or cardiac revascularization (PTCA, Stent or CABG) within 40 days of enrollment\n* Are currently participating in a clinical investigation that includes an active treatment arm\n* Are pregnant or planning to become pregnant during the duration of the study\n* Have a life expectancy of less than 6 months due to any condition\n* Are less than 18 years of age\n* Are unable to comply with the follow up schedule", "healthyVolunteers": false, "sex": "ALL", "minimumAge": "18 Years", "stdAges": ["ADULT", "OLDER_ADULT"]}, "contactsLocationsModule": {"overallOfficials": [{"name": "Gery Tomassoni, MD", "affiliation": "Central Baptist Hospital", "role": "STUDY_CHAIR"}], "locations": [{"facility": "University Hospital of Alabama at Birmingham", "city": "Birmingham", "state": "Alabama", "zip": "35233", "country": "United States", "geoPoint": {"lat": 33.52066, "lon": -86.80249}}, {"facility": "Baptist Health Medical Center", "city": "Little Rock", "state": "Arkansas", "zip": "72205", "country": "United States", "geoPoint": {"lat": 34.74648, "lon": -92.28959}}, {"facility": "Arkansas Heart Hospital", "city": "Little Rock", "state": "Arkansas", "zip": "72211", "country": "United States", "geoPoint": {"lat": 34.74648, "lon": -92.28959}}, {"facility": "Glendale Memorial Medical Center", "city": "Glendale", "state": "California", "zip": "91204", "country": "United States", "geoPoint": {"lat": 34.14251, "lon": -118.25508}}, {"facility": "University of Southern California", "city": "Los Angeles", "state": "California", "zip": "90033", "country": "United States", "geoPoint": {"lat": 34.05223, "lon": -118.24368}}, {"facility": "ACS Research Group", "city": "Mountain View", "state": "California", "zip": "94040", "country": "United States", "geoPoint": {"lat": 37.38605, "lon": -122.08385}}, {"facility": "Regional Cardiology Associates", "city": "Sacramento", "state": "California", "zip": "95819", "country": "United States", "geoPoint": {"lat": 38.58157, "lon": -121.4944}}, {"facility": "Scripps Green Hospital", "city": "San Diego", "state": "California", "zip": "92037", "country": "United States", "geoPoint": {"lat": 32.71533, "lon": -117.15726}}, {"facility": "Orlando Heart Center", "city": "Orlando", "state": "Florida", "zip": "32806", "country": "United States", "geoPoint": {"lat": 28.53834, "lon": -81.37924}}, {"facility": "The Heart and Vascular Institute of Florida - S. Pinellas", "city": "Saint Petersburg", "state": "Florida", "zip": "33705", "country": "United States", "geoPoint": {"lat": 27.77086, "lon": -82.67927}}, {"facility": "Piedmont Hospital", "city": "Atlanta", "state": "Georgia", "zip": "30309", "country": "United States", "geoPoint": {"lat": 33.749, "lon": -84.38798}}, {"facility": "Midwest Heart Foundation", "city": "Lombard", "state": "Illinois", "zip": "60148", "country": "United States", "geoPoint": {"lat": 41.88003, "lon": -88.00784}}, {"facility": "Central Baptist Hospital", "city": "Lexington", "state": "Kentucky", "zip": "40503", "country": "United States", "geoPoint": {"lat": 37.98869, "lon": -84.47772}}, {"facility": "Lahey Clinical Medical Center", "city": "Burlington", "state": "Massachusetts", "zip": "01805", "country": "United States", "geoPoint": {"lat": 42.50482, "lon": -71.19561}}, {"facility": "Thoracic Cardiovascular Healthcare Foundation", "city": "Lansing", "state": "Michigan", "zip": "48910", "country": "United States", "geoPoint": {"lat": 42.73253, "lon": -84.55553}}, {"facility": "Deborah Heart and Lung Center", "city": "Browns Mills", "state": "New Jersey", "zip": "08015", "country": "United States", "geoPoint": {"lat": 39.97261, "lon": -74.58293}}, {"facility": "Morristown Memorial Hospital", "city": "Morristown", "state": "New Jersey", "zip": "07962", "country": "United States", "geoPoint": {"lat": 40.79677, "lon": -74.48154}}, {"facility": "Mount Sinai Hospital", "city": "New York", "state": "New York", "zip": "10029", "country": "United States", "geoPoint": {"lat": 40.71427, "lon": -74.00597}}, {"facility": "The Cleveland Clinic Foundation", "city": "Cleveland", "state": "Ohio", "zip": "44195", "country": "United States", "geoPoint": {"lat": 41.4995, "lon": -81.69541}}, {"facility": "EMH Regional Medical Center", "city": "Elyria", "state": "Ohio", "zip": "44035", "country": "United States", "geoPoint": {"lat": 41.36838, "lon": -82.10765}}, {"facility": "Lancaster Heart Foundation", "city": "Lancaster", "state": "Pennsylvania", "zip": "17602", "country": "United States", "geoPoint": {"lat": 40.03788, "lon": -76.30551}}, {"facility": "Methodist University Hospital", "city": "Memphis", "state": "Tennessee", "zip": "38104", "country": "United States", "geoPoint": {"lat": 35.14953, "lon": -90.04898}}, {"facility": "St. Thomas Hospital", "city": "Nashville", "state": "Tennessee", "zip": "37205", "country": "United States", "geoPoint": {"lat": 36.16589, "lon": -86.78444}}, {"facility": "Arrhythmia Center for Southern Wisconsin", "city": "Milwaukee", "state": "Wisconsin", "zip": "53215", "country": "United States", "geoPoint": {"lat": 43.0389, "lon": -87.90647}}]}, "referencesModule": {"references": [{"pmid": "23339555", "type": "RESULT", "citation": "Tomassoni G, Baker J, Corbisiero R, Love C, Martin D, Niazi I, Sheppard R, Worley S, Beau S, Greer GS, Aryana A, Cao M, Harbert N, Zhang S; Promote(R) Q CRT-D and Quartet(R) Left Ventricular Heart Lead Study Group. Postoperative performance of the Quartet(R) left ventricular heart lead. J Cardiovasc Electrophysiol. 2013 Apr;24(4):449-56. doi: 10.1111/jce.12065. Epub 2013 Jan 22."}]}}, "resultsSection": {"participantFlowModule": {"groups": [{"id": "FG000", "title": "CRT-D and LV Lead", "description": "CRT-D and LV lead (Quartet\u2122 lead and Promote Q\u00ae device system): Promote Q CRT-D and Quartet LV lead"}], "periods": [{"title": "Overall Study", "milestones": [{"type": "STARTED", "achievements": [{"groupId": "FG000", "numSubjects": "178"}]}, {"type": "COMPLETED", "achievements": [{"groupId": "FG000", "numSubjects": "130"}]}, {"type": "NOT COMPLETED", "achievements": [{"groupId": "FG000", "numSubjects": "48"}]}], "dropWithdraws": [{"type": "Unsuccessful Implant", "reasons": [{"groupId": "FG000", "numSubjects": "8"}]}, {"type": "Death", "reasons": [{"groupId": "FG000", "numSubjects": "29"}]}, {"type": "Heart Transplant", "reasons": [{"groupId": "FG000", "numSubjects": "1"}]}, {"type": "Withdrawal by Subject", "reasons": [{"groupId": "FG000", "numSubjects": "6"}]}, {"type": "Lost to Follow-up", "reasons": [{"groupId": "FG000", "numSubjects": "1"}]}, {"type": "System Explant", "reasons": [{"groupId": "FG000", "numSubjects": "3"}]}]}]}, "baselineCharacteristicsModule": {"groups": [{"id": "BG000", "title": "CRT-D and LV Lead", "description": "CRT-D and LV lead (Quartet\u2122 lead and Promote Q\u00ae device system): Promote Q CRT-D and Quartet LV lead"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "178"}]}], "measures": [{"title": "Age, Continuous", "paramType": "MEAN", "dispersionType": "STANDARD_DEVIATION", "unitOfMeasure": "years", "classes": [{"categories": [{"measurements": [{"groupId": "BG000", "value": "68", "spread": "11"}]}]}]}, {"title": "Sex: Female, Male", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"categories": [{"title": "Female", "measurements": [{"groupId": "BG000", "value": "56"}]}, {"title": "Male", "measurements": [{"groupId": "BG000", "value": "122"}]}]}]}, {"title": "Race (NIH/OMB)", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"categories": [{"title": "American Indian or Alaska Native", "measurements": [{"groupId": "BG000", "value": "0"}]}, {"title": "Asian", "measurements": [{"groupId": "BG000", "value": "5"}]}, {"title": "Native Hawaiian or Other Pacific Islander", "measurements": [{"groupId": "BG000", "value": "0"}]}, {"title": "Black or African American", "measurements": [{"groupId": "BG000", "value": "29"}]}, {"title": "White", "measurements": [{"groupId": "BG000", "value": "140"}]}, {"title": "More than one race", "measurements": [{"groupId": "BG000", "value": "2"}]}, {"title": "Unknown or Not Reported", "measurements": [{"groupId": "BG000", "value": "2"}]}]}]}, {"title": "New York Heart Association Class", "description": "The New York Heart Association (NYHA) classification system is the most commonly used classification system for heart failure. Class I (least severe): No symptoms and no limitations on ordinary physical activity; Class II: Mild symptoms and slight limitations on ordinary physical activity; Class III: Marked limitation on activity due to symptoms; Class IV (most severe): Severe limitations and even symptoms at rest.", "paramType": "NUMBER", "unitOfMeasure": "participants", "classes": [{"title": "Class III", "categories": [{"measurements": [{"groupId": "BG000", "value": "175"}]}]}, {"title": "Class IV", "categories": [{"measurements": [{"groupId": "BG000", "value": "3"}]}]}]}]}, "outcomeMeasuresModule": {"outcomeMeasures": [{"type": "PRIMARY", "title": "Freedom From Left Ventricular Lead-Related Complications Through 3 Months", "description": "The primary safety endpoint for this study is freedom from left ventricular lead-related complications through 3 months.", "populationDescription": "Patients implanted with a Promote Q CRT-D device and Quartet LV lead.", "reportingStatus": "POSTED", "paramType": "NUMBER", "dispersionType": "97.5% Confidence Interval", "unitOfMeasure": "percentage probability", "timeFrame": "3 months", "groups": [{"id": "OG000", "title": "CRT-D and LV Lead", "description": "CRT-D and LV lead (Quartet\u2122 lead and Promote Q\u00ae device system): Promote Q CRT-D and Quartet LV lead"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "178"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "96", "lowerLimit": "93", "upperLimit": "NA", "comment": "Upper bound was not calculated for this outcome measure with one sided hypothesis"}]}]}]}, {"type": "PRIMARY", "title": "Freedom From System-related Complications Through 3 Months", "description": "The co-primary safety endpoint for this study is freedom from system-related complications through 3 months.", "populationDescription": "Participants implanted with a Promote Q CRT-D device and Quartet LV lead.", "reportingStatus": "POSTED", "paramType": "NUMBER", "dispersionType": "97.5% Confidence Interval", "unitOfMeasure": "percentage probability", "timeFrame": "3 Months", "groups": [{"id": "OG000", "title": "CRT-D and LV Lead", "description": "CRT-D and LV lead (Quartet\u2122 lead and Promote Q\u00ae device system): Promote Q CRT-D and Quartet LV lead"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "178"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "92", "lowerLimit": "88", "upperLimit": "NA", "comment": "Upper bound was not calculated for this outcome measure with one sided hypothesis"}]}]}]}, {"type": "PRIMARY", "title": "The Primary Effectiveness Endpoint for the Promote Q System Was the Responder Rate to Biventricular Pacing at 3 Months.", "description": "The primary effectiveness endpoint for the Promote Q system was the responder rate to biventricular pacing at 3 months. A responder per protocol was defined as a patient with an LV pacing threshold of \\<2.5 V at 0.5ms in the D1-M2 pacing configuration (Vector 1) AND at least one other non-standard programmable biventricular lead vector. Non-standard vectors included Vector 2 (D1-P4), Vector 4 (M2-P4), Vector 6 (M3-M2), Vector 7 (M3-P4), Vector 8 (M3-RV coil), Vector 9 (P4-M2) and Vector 10 (P4-RV coil).", "reportingStatus": "POSTED", "paramType": "NUMBER", "dispersionType": "97.5% Confidence Interval", "unitOfMeasure": "percentage of participants", "timeFrame": "3 Months", "groups": [{"id": "OG000", "title": "Patients Per Statistical Analysis Plan", "description": "Total number of participants enrolled in the study (with an attempted implant of a Promote Q CRT-D and Quartet LV lead including unsuccessful implants)."}, {"id": "OG001", "title": "Patients Per Complete Case Analysis", "description": "Complete case analysis includes only the number of patients that were successfully implanted with the Promote Q CRT-D and Quartet LV lead."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "178"}, {"groupId": "OG001", "value": "162"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "79.2", "lowerLimit": "72.5", "upperLimit": "NA", "comment": "Upper bound was not calculated for this outcome measure with one sided hypothesis"}, {"groupId": "OG001", "value": "83.3", "lowerLimit": "76.7", "upperLimit": "NA", "comment": "Upper bound was not calculated for this outcome measure with one sided hypothesis"}]}]}]}]}, "adverseEventsModule": {"frequencyThreshold": "0", "eventGroups": [{"id": "EG000", "title": "CRT-D and LV Lead", "description": "CRT-D and LV Lead", "seriousNumAffected": 0, "seriousNumAtRisk": 178, "otherNumAffected": 76, "otherNumAtRisk": 178}], "otherEvents": [{"term": "Complications", "organSystem": "Cardiac disorders", "stats": [{"groupId": "EG000", "numEvents": 36, "numAffected": 28, "numAtRisk": 178}]}, {"term": "Observations", "organSystem": "Cardiac disorders", "stats": [{"groupId": "EG000", "numEvents": 59, "numAffected": 48, "numAtRisk": 178}]}]}, "moreInfoModule": {"certainAgreement": {"piSponsorEmployee": false, "restrictiveAgreement": false}, "pointOfContact": {"title": "Clay Cohorn: Director, Clinical Study Management", "organization": "St. Jude Medical", "email": "ccohorn@sjm.com", "phone": "972 309 8087"}}}, "derivedSection": {"miscInfoModule": {"versionHolder": "2024-06-24"}, "conditionBrowseModule": {"meshes": [{"id": "D000006333", "term": "Heart Failure"}], "ancestors": [{"id": "D000006331", "term": "Heart Diseases"}, {"id": "D000002318", "term": "Cardiovascular Diseases"}], "browseLeaves": [{"id": "M9421", "name": "Heart Failure", "asFound": "Heart Failure", "relevance": "HIGH"}, {"id": "M9419", "name": "Heart Diseases", "relevance": "LOW"}], "browseBranches": [{"abbrev": "BC14", "name": "Heart and Blood Diseases"}, {"abbrev": "All", "name": "All Conditions"}]}, "interventionBrowseModule": {"meshes": [{"id": "C000072593", "term": "Ethinyl estradiol, levonorgestrel drug combination"}], "ancestors": [{"id": "D000080066", "term": "Contraceptive Agents, Hormonal"}, {"id": "D000003270", "term": "Contraceptive Agents"}, {"id": "D000012102", "term": "Reproductive Control Agents"}, {"id": "D000045505", "term": "Physiological Effects of Drugs"}, {"id": "D000003277", "term": "Contraceptives, Oral, Combined"}, {"id": "D000003276", "term": "Contraceptives, Oral"}, {"id": "D000003271", "term": "Contraceptive Agents, Female"}], "browseLeaves": [{"id": "M265601", "name": "Ethinyl estradiol, levonorgestrel drug combination", "asFound": "Neobladder", "relevance": "HIGH"}, {"id": "M19256", "name": "Levonorgestrel", "relevance": "LOW"}, {"id": "M8145", "name": "Ethinyl Estradiol", "relevance": "LOW"}, {"id": "M8108", "name": "Estradiol", "relevance": "LOW"}, {"id": "M266279", "name": "Estradiol 17 beta-cypionate", "relevance": "LOW"}, {"id": "M266280", "name": "Estradiol 3-benzoate", "relevance": "LOW"}, {"id": "M234941", "name": "Polyestradiol phosphate", "relevance": "LOW"}, {"id": "M6494", "name": "Contraceptive Agents", "relevance": "LOW"}, {"id": "M2116", "name": "Contraceptive Agents, Hormonal", "relevance": "LOW"}, {"id": "M6500", "name": "Contraceptives, Oral", "relevance": "LOW"}, {"id": "M6501", "name": "Contraceptives, Oral, Combined", "relevance": "LOW"}, {"id": "M6495", "name": "Contraceptive Agents, Female", "relevance": "LOW"}], "browseBranches": [{"abbrev": "Repr", "name": "Reproductive Control Agents"}, {"abbrev": "All", "name": "All Drugs and Chemicals"}]}}, "hasResults": true}